The joint venture announcement is really great news. My

New Post Public Reply Private Reply Replies (1) Message Board
investorxc Bornet #23568
The joint venture announcement is really great news. My biggest fear all along has been if GC did another "spinoff" deal like AVDX leaving the shareholders with nothing- he spoke about that possibility at a presentation he did a few months ago. Bottom line is AMBS needs cash and now. Best case scenario is for them to partner ESS and get a nice upfront payment which they could use to pay off Magna.

The fact they have entered into an exclusivity agreement says they are pretty far along in the negotiations. I always doubted Big pharma would partner on ESS until it has a completed and successful phase 2. In my conversation with Gregg Linn a few months ago about AVDX, he told me Roche told him to come back to them once FDA granted clearance to OvaDX- just too much risk for them until that occurs. So likewise with ESS, I think a large company just doesn't want to take on the risk at this stage.

The 8k describes the company as a "commercial -stage wound company:" I think it's probably a smaller company, possibly private. I owned TTNP a few years ago- it took them about a year to negotiate a partnership deal for their Probuphine. In March they were in "term sheet negotiations" and they didn't close the deal until Dec. AMBS aquired ESS last summer, so I wouldn't have expected them to have been able to close a deal before now. All that really matters is how much they can get up front and if it's enough to pay off Magna.

As a side note,that Hipparchus guy has been posting nonsense on Twitter for the past few months- "first patient being treated next week, financing deal done" etc, etc. none of it was ever true and then he'd remove the post the next day. This week he posted this- and it turned out to actually be true- unbelievable!

1. hipparchus ‏@hipparchus70 3h3 hours ago
$ambs I told you 4 days before the deal !!! I am also hearing that the JV partner values ESS at $750 million. Let us see if $AMBS can go +$4

2. hipparchus ‏@hipparchus70 Jun 27
Congrats all. Rumors were right. $ambs has clinched an eye-popping deal. Salute @G_Commish's leadership. PR on 30 June will make headlines.

3. hipparchus ‏@hipparchus70 Jun 24
$ambs alert: "a deal is imminent" This was told to me by a common shareholder who is in @G_Commish's contacts and spoke w/ him yesterday.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Jiuzi Holdings Makes Strategic Moves in Crypto Custody Services

Updated Category News Views 95

Jiuzi Holdings Innovates in Cryptocurrency Custody Jiuzi Holdings, Inc. (NASDAQ: JZXN) recently announced an exciting partnership with EXSAT.NETWORK LTD, a core organization within the EOS cryptocurrency project. This collaboration aims to venture into a cryptocurrency custody business projected to reach a staggering scale of up to $3 billion. Exploring New Horizons This...

Continue Reading
Breakthrough Insights into MP0712 and DLL3 Targeting Beyond 2025

Updated Category News Views 226

Advancements in DLL3 Targeting with MP0712 Molecular Partners is thrilled to share groundbreaking insights regarding MP0712, their innovative Radio-DARPin targeting DLL3, presented at the Targeted Radiopharmaceuticals Summit Europe. This development marks a significant milestone in the treatment landscape for small cell lung cancer (SCLC) and other neuroendocrine cancers....

Continue Reading
Exclusive 300-Acre Estate in NY's Adirondacks Up for Auction

Updated Category News Views 270

Luxury Auction of a 300-Acre Estate in the Adirondacks A spectacular 300-acre estate in the Adirondacks is being auctioned off, presenting a rare opportunity for affluent buyers seeking a piece of pristine wilderness. This remarkable property is set to sell at a luxury auction, where the highest bidder will take ownership at or above a reserve price of $2.3 million....

Continue Reading
Katie Strout Elevates Marketing Strategy as Highspring CMO

Updated Category News Views 212

Katie Strout Elevates Marketing Strategy at Highspring Katie Strout has been appointed as Chief Marketing Officer (CMO) of Highspring, ushering in a new era of enterprise growth. Strout has had a considerable impact on repositioning Highspring's consulting, managed services, and talent solutions, helping improve business agility for its clients. This milestone comes...

Continue Reading
Essential Voice Care Tips for Educators and Students Alike

Updated Category News Views 128

Protecting Your Voice: A Back-to-School Essential The American Speech-Language-Hearing Association (ASHA) emphasizes the importance of voice care for teachers and students as they head back to the classroom. With the school year kicking into full gear, many will be using their voices extensively, making it essential to practice vocal health. Why Voice Care is Vital For...

Continue Reading